Bruker reported third-quarter 2026 revenue of $874.0 million, up 1.6% from a year earlier, and non-GAAP diluted EPS of $0.56, up 24.4%. GAAP results were a diluted loss of $(0.81) per share, driven by a $174.5 million goodwill impairment charge, and the company reconfirmed its FY26 organic revenue growth and non-GAAP EPS guidance of $2.10 to $2.15.
Q3-26 revenue $874.0 million, up 1.6% yoy; organic growth 0.7%
Q3-26 non-GAAP diluted EPS $0.56, up 24.4% from $0.45; GAAP diluted loss $(0.81) vs. $(0.41) a year earlier
Q3-26 GAAP operating loss $(91.0) million, including a $174.5 million goodwill impairment charge
FY26 non-GAAP EPS outlook of $2.10 to $2.15 reconfirmed; FY26 revenue guidance $3.52 to $3.56 billion
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Bruker's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$3.44B
+2.1%
$-0.15
-119.7%
-0.3%
FY2024
$3.37B
+13.6%
$0.76
-73.8%
3.4%
FY2023
$2.96B
+17.1%
$2.90
+45.7%
14.4%
FY2022
$2.53B
+4.7%
$1.99
+9.9%
11.7%
FY2021
$2.42B
+21.7%
$1.81
+77.5%
11.5%
Frequently asked questions
When is Bruker's next earnings date?
Bruker has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Bruker earn last quarter?
For the quarter ended Sep 2026, Bruker reported diluted EPS of $-0.81 on revenue of $874.00M (+1.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.